Veterinary Antimicrobial Susceptibility Testing in United States Trends and Forecast
The future of the veterinary antimicrobial susceptibility testing market in United States looks promising, with opportunities in the veterinary reference laboratory and veterinary research institutes & universities markets. The global veterinary antimicrobial susceptibility testing market is expected to reach an estimated $59.2 billion by 2031, with a CAGR of 6.3% from 2025 to 2031. The veterinary antimicrobial susceptibility testing market in United States is also forecasted to witness strong growth over the forecast period. The major drivers for this market are the escalating danger of antimicrobial resistance is a result of the excessive use of antibiotics, increasing demand for animal-derived products, and rising prevalence of zoonotic diseases.
• Lucintel forecasts that, within the animal type category, food-producing animal is expected to witness the higher growth over the forecast period.
• Within the end use category, veterinary reference laboratories is expected to witness the highest growth.
Emerging Trends in the Veterinary Antimicrobial Susceptibility Testing Market in United States
Over the past few years, the United States veterinary antimicrobial susceptibility testing (AST) market has seen considerable growth. This is influenced by growing recognition of antimicrobial resistance (AMR) and changing regulations in veterinary medicine. With the agricultural and animal health industries targeting the prevention of AMR, advances in diagnostic testing and more precise treatment interventions have become prominent. These trends are a result of both technological innovations and the demand for more environmentally friendly animal care. Understanding these trends is crucial for veterinary stakeholders to effectively cope with changes.
• Greater Emphasis on Accelerated Diagnostic Testing: The increased need for faster, more reliable diagnostic tests is pushing the boundaries of accelerated antimicrobial susceptibility testing. Real-time diagnostics enable veterinarians to customize treatments, minimizing broad-spectrum antibiotic use and the risk of resistance emergence. These developments are particularly crucial in high-risk settings, including veterinary clinics and farms, where quick, precise results can avoid the spread of infectious disease outbreaks.
• Combination of Machine Learning and Artificial Intelligence: Machine learning and artificial intelligence are transforming the veterinary antimicrobial susceptibility testing marketplace by facilitating the processing of big datasets to create predictive models. Both technologies make it possible to interpret antimicrobial susceptibility patterns at high speed, assisting veterinarians in anticipating resistance patterns and choosing the best treatments. In the long run, AI-based systems can refine treatment protocols and reduce the utilization of antibiotics, contributing significantly to the prevention of antimicrobial resistance.
• Greater Regulatory Scrutiny and Conformity: Governments and regulatory agencies are making their regulations on the use of antibiotics in animal health more stringent. Greater emphasis on compliance has resulted in a greater need for accurate antimicrobial susceptibility testing to ensure proper use of antibiotics and counter the emerging problem of antimicrobial resistance. Veterinary professionals now need to remain current with these changing regulations in order to remain in compliance, which has resulted in wider use of AST in practice.
• Point-of-Care Testing Devices Usage: Point-of-care diagnostic instruments are increasingly used in veterinary clinics, offering direct antimicrobial susceptibility results at the site of patient care. Faster decision-making is provided by these devices, and it enhances patient care by allowing prompt interventions. POC devices are being used increasingly, particularly in rural and disadvantaged regions, where access to sophisticated diagnostic laboratories is limited.
• Personalized Approach to Veterinary Medicine: Personalized veterinary medicine is increasing, fueled by improved and faster antimicrobial susceptibility testing. Personalized medicine applies custom treatments to individual animals based on their susceptibility profile, allowing for greater success in the treatment of animals. Personalized medicine not only enhances animal health but also decreases unnecessary antibiotic use, which is critical to preventing antimicrobial resistance.
These new trends are revolutionizing the United States veterinary antimicrobial susceptibility testing market by placing more focus on rapid testing, AI adoption, regulatory adherence, point-of-care testing, and tailored treatments. These trends show an increased interest in preventing antimicrobial resistance while ensuring that animals get the best treatment possible.
Recent Developments in the Veterinary Antimicrobial Susceptibility Testing Market in United States
The United States veterinary antimicrobial susceptibility testing (AST) market has experienced a chain of developments in the past few years. These advancements owe their occurrence mainly to growing antimicrobial resistance (AMR) concerns and demands for more accurate treatments in animal healthcare. These developments not only enhanced veterinary care but also played a role in regulatory and technological trends within the industry.
• New Diagnostic Technologies: The market has experienced the emergence of new diagnostic technologies that enhance the speed and accuracy of antimicrobial susceptibility tests. These technologies involve automated systems and multiplex assays, which have the ability to analyze multiple pathogens as well as their resistance profiles at once. The adoption of these diagnostic devices in veterinary practices has facilitated the faster identification of resistant pathogens and the prescription of more targeted treatments, thereby decreasing the use of unnecessary antibiotics.
• Growth of Veterinary Diagnostics Market: The rising demand for reliable AST has fueled the growth of the veterinary diagnostics market. Numerous new entrants have joined the market, offering new testing platforms and services. As veterinary professionals seek more accurate, precise, and affordable solutions, manufacturers are concentrating on the production of products addressing these issues. This growth mirrors the increasing recognition of ASTs role in combating antimicrobial resistance.
• Regulatory Framework for AMR in Veterinary Medicine: New rules and guidelines, including the FDAs Veterinary Feed Directive (VFD), are molding the market by demanding more stringent antibiotic use guidelines in livestock and pet animals. These regulations have created a higher demand for AST to facilitate compliance with the responsible use of antibiotics. The implementation of such frameworks has ensured that antimicrobial stewardship becomes a top priority for veterinary clinics.
• Partnerships and Collaborations: There has been a remarkable rise in collaboration between veterinary organizations, pharmaceutical firms, and diagnostic companies. These collaborations are emphasizing the design of more efficient and precise antimicrobial susceptibility testing solutions. By sharing expertise across these industries, these collaborations are looking to speed up the release of effective testing tools and treatments.
• Development of Animal Health Data Solutions: The emergence of digital health platforms is revolutionizing the veterinary sector, allowing veterinarians to monitor and analyze antimicrobial susceptibility data in a more effective manner. Through the collection and analysis of voluminous data, such solutions offer insights that can inform future treatment procedures. This innovation improves the decision-making process for veterinarians, enhancing animal health results and promoting more prudent antibiotic use.
These recent advancements reflect the continued innovation and growth in the veterinary antimicrobial susceptibility testing market. The heightened emphasis on cutting-edge diagnostics, regulatory actions, collaborations, and data-driven solutions is reshaping the landscape, with the ultimate aim of enhancing animal health while mitigating the worlds threat of antimicrobial resistance.
Strategic Growth Opportunities for Veterinary Antimicrobial Susceptibility Testing Market in United States
The United States veterinary antimicrobial susceptibility testing (AST) market is experiencing robust growth with advancements in technology, increased awareness of antimicrobial resistance (AMR), and changing regulatory needs. These trends have created numerous strategic opportunity spaces for growth in different applications, from diagnostic testing to individualized veterinary medicine. The prominent market applications are projected to grow as the stakeholders align with meeting the growing demand for efficient and quick solutions.
• Point-of-Care Diagnostics: Point-of-care testing (POC) presents a major growth potential, as it provides instant antimicrobial susceptibility results during the veterinary visit. This technology simplifies decision-making, eliminating the need for lengthy laboratory procedures. With increasing numbers of veterinary clinics implementing POC devices, real-time testing and same-day treatment options will drive increasing demand, especially in rural or resource-poor areas.
• Antimicrobial Resistance Surveillance: With the increasing danger of AMR, opportunities are increasing to create surveillance programs that track antimicrobial resistance patterns among different animal populations. These will serve as useful information that can inform the creation of new test protocols and treatment protocols. Partnerships with governments and agricultural organizations to install surveillance systems will be a primary growth opportunity in the future.
• Telemedicine and Remote Diagnostics: The incorporation of telemedicine in veterinary treatment presents a special opportunity for the market. Remote diagnostic testing with antimicrobial susceptibility testing can offer greater access, particularly to rural communities where proximity to specialist veterinary practitioners is not a possibility. Through this opportunity, veterinary professionals can be linked with specialists and obtain expert advice on AST results interpretation in real-time.
• Personalized Veterinary Medicine: With the advancements in antimicrobial susceptibility testing, personalized medicine for pets is increasingly being adopted. Treating based on personal susceptibility profiles minimizes the unnecessary application of antibiotics and guarantees more effective therapy. The growth of personalized veterinary medicine will lead to great growth opportunities for AST providers able to supply accurate, tailored diagnostic solutions.
• Veterinary Antimicrobial Stewardship Programs: With regulatory agencies nudging the use of antibiotics responsibly, there is increasing potential for the application of antimicrobial stewardship programs in veterinary clinics. These programs aim to optimize antibiotic use through the integration of AST results into treatment, encouraging effective therapy, and minimizing the requirement for antibiotics overall. The application of these programs is likely to grow with government as well as industry players backing efforts against antimicrobial resistance.
The United States veterinary antimicrobial susceptibility testing market strategic growth opportunities are varied and indicative of the continued emphasis on enhancing animal health while confronting antimicrobial resistance. Point-of-care diagnostic innovation, surveillance, telemedicine, personalized medicine, and stewardship programs are forecast to create further growth in this essential segment.
Veterinary Antimicrobial Susceptibility Testing Market in United States Driver and Challenges
The United States veterinary antimicrobial susceptibility testing (AST) market is influenced by a range of technological, economic, and regulatory drivers. Although the market undergoes significant growth, various drivers and challenges influence its development. It is these drivers and challenges that help stakeholders predict alterations and conform to increasing demands for good antimicrobial resistance management in the veterinary practice.
The factors responsible for driving the veterinary antimicrobial susceptibility testing market in the United States include:
• Raising Antimicrobial Resistance Awareness: With the threat of antimicrobial resistance (AMR) in the world increasingly becoming self-evident, raising awareness of the requirement for useful antimicrobial susceptibility testing is gaining traction. This has fueled the demand for more precise and dependable testing solutions to fight resistance in livestock as well as companion animals. Veterinarians are more keen than ever to choose the most suitable antibiotics to reduce resistance.
• Technology Advances in Diagnostics: The advances in faster and more precise diagnostic equipment are a major growth driver in the veterinary antimicrobial susceptibility testing market. Advances in technology, including multiplex assays, PCR-based testing, and diagnostics with AI, have eased testing protocols and enhanced the accuracy of results. These advances are broadening access and reducing the cost of AST for veterinary practitioners.
• Raised Regulatory Pressure: Governments are enforcing more stringent regulations on the usage of antibiotics within animals, especially in agriculture. Such regulations are necessitating high-quality antimicrobial susceptibility testing for them to comply with ethical antibiotic usage. Veterinary clinics are increasingly being mandated to conduct AST to comply with these changing regulations.
• Increased Spending on Veterinary Care: With the increasing number of pets in the United States, so is the need for quality veterinary care. This trend is fueling the implementation of sophisticated diagnostic equipment, such as antimicrobial susceptibility testing. Pet owners are more and more looking for the best for their pets, which increases the demand for timely and precise AST.
• Animal Health and Food Safety: Increased emphasis on animal health, food safety, and judicious use of antibiotics in livestock production is driving the use of antimicrobial susceptibility testing. Through enhanced animal health and reduced resistance, AST becomes critical to enabling safe food production. This increased emphasis is projected to further increase the veterinary antimicrobial susceptibility testing market.
Challenges in the veterinary antimicrobial susceptibility testing market in the United States are:
• High Cost of Advanced Diagnostic Equipment: Although increased technological advances have enhanced the efficacy of antimicrobial susceptibility tests, the use of advanced diagnostic equipment is still a hindrance for most veterinary clinics, particularly small ones. High start-up expenditures as well as regular maintenance costs may discourage the use of the equipment, especially in resource-poor regions.
• Limited Access to Specialized Laboratories: In some areas, such as rural or remote communities, there is poor access to specialized laboratories with the facilities to undertake antimicrobial susceptibility testing. This contributes to longer delays in diagnosis and effective treatment, resulting in worse health for animals and ongoing transmission of antimicrobial resistance.
• Sophisticated Regulatory Environment: The changing regulatory environment for antimicrobial use in veterinary medicine is a challenge to the industry. Veterinary practices have to keep themselves informed about changing regulations in order to be compliant. Complexity in these regulations may, at times, create confusion and delays in implementing essential testing protocols.
The challenges and drivers in the veterinary antimicrobial susceptibility testing market are determining its growth path. Although drivers such as mounting AMR awareness, advancements in technology, and regulatory push are propelling growth, challenges such as the exorbitant price of sophisticated tools and limited availability of specialized labs are holding back wider adoption. Overcoming these hurdles will be imperative to the market sustained success.
List of Veterinary Antimicrobial Susceptibility Testing Market in United States Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies, veterinary antimicrobial susceptibility testing companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the veterinary antimicrobial susceptibility testing companies profiled in this report include:
• Company 1
• Company 2
• Company 3
• Company 4
• Company 5
• Company 6
• Company 7
• Company 8
• Company 9
• Company 10
Veterinary Antimicrobial Susceptibility Testing Market in United States by Segment
The study includes a forecast for the veterinary antimicrobial susceptibility testing market in United States by animal type, product type, and end use.
Veterinary Antimicrobial Susceptibility Testing Market in United States by Animal Type [Analysis by Value from 2019 to 2031]:
• Food-producing Animals
• Companion Animals
Veterinary Antimicrobial Susceptibility Testing Market in United States by Product Type [Analysis by Value from 2019 to 2031]:
• Disks & Plates
• Culture Media
• Accessories & Consumables
• Automated AST Instruments
Veterinary Antimicrobial Susceptibility Testing Market in United States by End Use [Analysis by Value from 2019 to 2031]:
• Veterinary Reference Laboratory
• Veterinary Research Institutes & Universities
• Other
Features of the Veterinary Antimicrobial Susceptibility Testing Market in United States
Market Size Estimates: Veterinary antimicrobial susceptibility testing in United States market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends and forecasts by various segments.
Segmentation Analysis: Veterinary antimicrobial susceptibility testing in United States market size by animal type, product type, and end use in terms of value ($B).
Growth Opportunities: Analysis of growth opportunities in different animal types, product types, and end uses for the veterinary antimicrobial susceptibility testing in United States.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the veterinary antimicrobial susceptibility testing in United States.
Analysis of competitive intensity of the industry based on Porters Five Forces model.
If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.
FAQ
Q1. What are the major drivers influencing the growth of the veterinary antimicrobial susceptibility testing market in United States?
Answer: The major drivers for this market are escalating danger of antimicrobial resistance is a result of the excessive use of antibiotics, increasing demand for animal-derived products, and rising prevalence of zoonotic diseases.
Q2. What are the major segments for veterinary antimicrobial susceptibility testing market in United States?
Answer: The future of the veterinary antimicrobial susceptibility testing market in United States looks promising with opportunities in the veterinary reference laboratory and veterinary research institutes & universities markets.
Q3. Which veterinary antimicrobial susceptibility testing market segment in United States will be the largest in future?
Answer: Lucintel forecasts that food-producing animals is expected to witness the higher growth over the forecast period.
Q4. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 10 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the veterinary antimicrobial susceptibility testing market in United States by animal type (food-producing animals and companion animals), product type (disks & plates, culture media, accessories & consumables, and automated AST instruments), and end use (veterinary reference laboratory, veterinary research institutes & universities, and other)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.4. What are the business risks and competitive threats in this market?
Q.5. What are the emerging trends in this market and the reasons behind them?
Q.6. What are some of the changing demands of customers in the market?
Q.7. What are the new developments in the market? Which companies are leading these developments?
Q.8. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.9. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.10. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Veterinary Antimicrobial Susceptibility Testing Market in United States, Veterinary Antimicrobial Susceptibility Testing Market in United States Size, Veterinary Antimicrobial Susceptibility Testing Market in United States Growth, Veterinary Antimicrobial Susceptibility Testing Market in United States Analysis, Veterinary Antimicrobial Susceptibility Testing Market in United States Report, Veterinary Antimicrobial Susceptibility Testing Market in United States Share, Veterinary Antimicrobial Susceptibility Testing Market in United States Trends, Veterinary Antimicrobial Susceptibility Testing Market in United States Forecast, Veterinary Antimicrobial Susceptibility Testing Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.